HomeInsightsStock Comparison

Divis Laboratories Ltd vs Sai Life Sciences Ltd Stock Comparison

Divis Laboratories Ltd vs Sai Life Sciences Ltd Stock Comparison

Last Updated on: Apr 27, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6009 as of 25 Apr 15:30.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 56.9 on March 2024 . This represents a CAGR of 8.24% over 5 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 91234 crore on March 2024 . This represents a CAGR of 11.57% over 5 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Divis Laboratories Ltd for the Dec '24 is ₹ 2401 crore as compare to the Sep '24 revenue of ₹ 2444 crore. This represent the decline of -1.76% The revenue of Sai Life Sciences Ltd for the Dec '24 is ₹ 448.89 crore as compare to the Sep '24 revenue of ₹ 405.52 crore. This represent the growth of 10.69%.
  • The ebitda of Divis Laboratories Ltd for the Dec '24 is ₹ 825 crore as compare to the Sep '24 ebitda of ₹ 822 crore. This represent the growth of 0.36% The ebitda of Sai Life Sciences Ltd for the Dec '24 is ₹ 128.87 crore as compare to the Sep '24 ebitda of ₹ 112.17 crore. This represent the growth of 14.89%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 589 crore over 7 quarters. This represents a CAGR of 33.34% The net profit of Sai Life Sciences Ltd changed from ₹ 39.61 crore to ₹ 53.85 crore over 5 quarters. This represents a CAGR of 27.85% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 50.44 % on March 2024 . This represents a CAGR of 8.83% over 5 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Sai Life Sciences Ltd

  • Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
  • Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
  • Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

Divis Laboratories Ltd News Hub

News

Divis Lab spurts as broker maintains buy call

In its latest note, the broker highlighted Divi's strong potential to emerge as a primary ...

Read more

24 Apr 2025 13:45

News

Divis Labs jumps on signing long-term manufacturing pact with global pharma major

In a regulatory filing on 18 April 2025, Divi's stated that the agreement pertains to the ...

Read more

21 Apr 2025 10:18

News

Divis Laboratories enters into long term manufacturing and supply agreement

Divis Laboratories has signed a long term manufacturing and supply agreement with a global...

Read more

18 Apr 2025 10:02

News

Divi's Laboratories announces change in senior management

Divi's Laboratories announced that G. Bala Kishore, serving as General Manager (EHS) of th...

Read more

31 Mar 2025 10:14

News

Volumes jump at Divis Laboratories Ltd counter

IndusInd Bank Ltd, Axis Bank Ltd, Gujarat State Petronet Ltd, Kaynes Technology India Ltd ...

Read more

12 Mar 2025 11:00

News

Divis Laboratories Ltd spurts 2.08%, up for third straight session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

13 Feb 2025 13:05

Sai Life Sciences Ltd News Hub

News

Volumes soar at Sai Life Sciences Ltd counter

Data Patterns (India) Ltd, K E C International Ltd, Elgi Equipments Ltd, Doms Industries L...

Read more

15 Apr 2025 14:30

News

Sai Life Sciences inaugurates Peptide Research Center in Hyderabad

 Sai Life Sciences has inaugurated a dedicated Peptide Research Center at its integrated R...

Read more

04 Apr 2025 13:58

News

Sai Life Sciences schedules board meeting

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 6 Februa...

Read more

24 Jan 2025 13:43

News

Sai Life Sciences spurts on debut

The scrip was listed at Rs 660, exhibiting a premium of 20.22% to the issue price. So far,...

Read more

18 Dec 2024 10:25

News

Shares of Sai Life Sciences lists today

The equity shares of Sai Life Sciences (Scrip Code: 544306) are listed effective 18 Decemb...

Read more

18 Dec 2024 09:25

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sai Life Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Sai Life Sciences Ltd?

Market cap of Divis Laboratories Ltd is 159,525 Cr while Market cap of Sai Life Sciences Ltd is 14,360 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Sai Life Sciences Ltd?

The stock performance of Divis Laboratories Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Sai Life Sciences Ltd?

As of April 27, 2025, the Divis Laboratories Ltd stock price is INR ₹6009.2. On the other hand, Sai Life Sciences Ltd stock price is INR ₹689.0.

How do dividend payouts of Divis Laboratories Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions